Recently, peripheral overexpression of FNDC5/irisin by intravenous application of an adenoviral vector was reported to impact memory impairment and improve synaptic plasticity in a mouse model of Alzheimer’s disease [18]. This evidence concerns the gene FNDC5 and early-onset autosomal dominant Alzheimer disease.